[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health":3,"$fff8lviv8jjf6":14},{"ok":4,"db":5,"lastOrangeBookRun":6,"lastDrugsFdaRun":9,"lastAlertsRun":12,"stale":13},true,"ok",{"status":5,"startedAt":7,"finishedAt":8,"lastOkAt":8},"2026-10-26T06:44:32.239Z","2026-10-26T06:44:53.640Z",{"status":5,"startedAt":10,"finishedAt":11,"lastOkAt":11},"2026-10-26T06:45:02.648Z","2026-10-26T06:45:13.189Z",null,false,{"name":15,"company":16,"products":21,"catalysts":30},"GLAXO GRP ENGLAND",{"name":17,"ticker":18,"exchange":19,"cik":20},"GSK plc","GSK","NYSE","0001131399",[22],{"tradeName":23,"slug":24,"ingredient":25,"applNo":26,"loe":27,"basis":28,"carveOutPossible":13,"strengths":29},"INCRUSE ELLIPTA","incruse-ellipta","UMECLIDINIUM BROMIDE","205382","2027-12-18","patent",1,[]]